You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Atezolizumab in patients with renal insufficiency and mixed variant histology: analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelial carcinoma

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Atezolizumab in patients with renal insufficiency and mixed variant histology: analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelial carcinoma

 

Online download statistics by month:

Online download statistics by month: July 2020 to March 2024

AbstractFullPdf
Jul 2020439440105
Aug 202013913843
Sep 2020868628
Oct 2020606018
Nov 202027279
Dec 202046468
Jan 2021626214
Feb 2021656512
Mar 202111311320
Apr 202110110112
May 2021888811
Jun 2021747411
Jul 202113413418
Aug 2021606010
Sep 2021676715
Oct 2021777725
Nov 2021686726
Dec 2021747414
Jan 202277788
Feb 2022636512
Mar 2022323213
Apr 2022475112
May 2022424315
Jun 2022596110
Jul 2022828712
Aug 2022889013
Sep 2022787913
Oct 2022788128
Nov 2022787811
Dec 2022575710
Jan 2023737313
Feb 202393938
Mar 2023676812
Apr 202340403
May 202327276
Jun 202336364
Jul 2023464616
Aug 202330307
Sep 202324244
Oct 202340408
Nov 202325254
Dec 202334347
Jan 202426277
Feb 2024262610
Mar 2024222231
Total31703192696